-Bloomberg
New Studies Validating The Uniqueness Of The BVA-100 Blood Test For Heart Failure Patients Compared To Pressure Measures; Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With BVA-Guided Care
Patient One-Year Mortality Rate 5.6% with BVA-Guided Care Compared to 36.8% in Control Group -
Data Presented at Key Scientific Meeting
Oak Ridge, TN, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Daxor
